Derazantinib: an investigational drug for the treatment of cholangiocarcinoma.
Braun S, McSheehy P, Litherland K, McKernan P, Forster-Gross N, Bachmann F, El-Shemerly M, Dimova-Dobreva M, Polyakova I, Häckl M, Zhou P, Lane H, Kellenberger L, Engelhardt M.
Braun S, et al. Among authors: kellenberger l.
Expert Opin Investig Drugs. 2021 Nov;30(11):1071-1080. doi: 10.1080/13543784.2021.1995355. Epub 2021 Nov 9.
Expert Opin Investig Drugs. 2021.
PMID: 34698609
Review.